Akumin Inc
NASDAQ:AKU
Intrinsic Value
Akumin, Inc. engages in the provision of outpatient diagnostic imaging services. [ Read More ]
The intrinsic value of one AKU stock under the Base Case scenario is 12.42 USD. Compared to the current market price of 0.33 USD, Akumin Inc is Undervalued by 97%.
Fundamental Analysis
Balance Sheet Decomposition
Akumin Inc
Current Assets | 176.5m |
Cash & Short-Term Investments | 45.4m |
Receivables | 114.7m |
Other Current Assets | 16.4m |
Non-Current Assets | 1.5B |
PP&E | 366.2m |
Intangibles | 1.2B |
Other Non-Current Assets | 23.5m |
Current Liabilities | 162.4m |
Accounts Payable | 25.5m |
Accrued Liabilities | 108.7m |
Other Current Liabilities | 28.2m |
Non-Current Liabilities | 1.6B |
Long-Term Debt | 1.3B |
Other Non-Current Liabilities | 363m |
Earnings Waterfall
Akumin Inc
Revenue
|
751m
USD
|
Cost of Revenue
|
-560.8m
USD
|
Gross Profit
|
190.2m
USD
|
Operating Expenses
|
-139.3m
USD
|
Operating Income
|
50.9m
USD
|
Other Expenses
|
-212m
USD
|
Net Income
|
-161.1m
USD
|
Free Cash Flow Analysis
Akumin Inc
What is Free Cash Flow?
AKU Profitability Score
Profitability Due Diligence
Akumin Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
Akumin Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
AKU Solvency Score
Solvency Due Diligence
Akumin Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.
Score
Akumin Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AKU Price Targets Summary
Akumin Inc
According to Wall Street analysts, the average 1-year price target for AKU is 0.75 USD .
Ownership
AKU Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
AKU Price
Akumin Inc
Average Annual Return | -20.86% |
Standard Deviation of Annual Returns | 14.75% |
Max Drawdown | -97% |
Market Capitalization | 29.9m USD |
Shares Outstanding | 89 516 500 |
Percentage of Shares Shorted | 5.71% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Akumin, Inc. engages in the provision of outpatient diagnostic imaging services. The company is headquartered in Plantation, Florida and currently employs 3,859 full-time employees. The company went IPO on 2017-12-01. The firm provides imaging procedures, which include magnetic resonance imaging (MRI), computerized tomography (CT), positron emission tomography (PET and PET/CT), ultrasound, diagnostic radiology (X-ray), mammography and other related procedures. Its cancer care services include a full suite of radiation therapy and related offerings. The firm through a network of approximately 200 owned and/or operated imaging locations, outpatient radiology and oncology services and solutions to approximately 1,000 hospitals and health systems across over 46 states. Its center locations include Delaware, Florida North, Florida Central, Florida South, Florida West, Illinois, Kansas, Massachusetts, Pennsylvania North, Pennsylvania South, Texas Dallas-Fort Worth, Texas El Paso, Texas North and Texas South. Its subsidiaries include Advanced Diagnostic Group, LLC, Advanced Diagnostic Resources, LLC and Affiliated PET Systems, LLC.